Description
| Product Name | CAT.No | Size |
| AFP | BXL0802A | 96T |
Product Description
The Biorex Diagnostics Alpha-Fetoprotein CLIA Kit is a high-sensitivity microplate chemiluminescence immunoassay (CLIA) designed for the quantitative determination of AFP in human serum. AFP is a critical glycoprotein biomarker, naturally produced during fetal development, and its measurement is widely used for prenatal screening, liver disease assessment, and oncology diagnostics.
Accurate monitoring of Alpha-Fetoprotein levels is essential for detecting liver disorders such as hepatocellular carcinoma, identifying high-risk pregnancies, and tracking tumour progression in oncology patients. Elevated or abnormal AFP concentrations provide clinicians with vital information for early diagnosis, treatment planning, and patient management.
The Biorex Diagnostics AFP CLIA Kit employs a solid-phase chemiluminescent immunoassay, providing high sensitivity and specificity to ensure reliable detection across physiologically and clinically relevant AFP ranges. The microplate format allows for consistent reproducibility across multiple assay runs and laboratories, offering dependable performance for both routine clinical diagnostics and specialized research applications.
This ready-to-use kit includes all necessary reagents, standards, and controls, streamlining workflow and minimizing preparation errors. Its design ensures compatibility with standard CLIA microplate readers, enabling efficient and high-throughput testing in hospitals, clinical laboratories, and research settings.
Key Features and Benefits
- Quantitative CLIA Microplate Assay: Provides precise measurement of AFP concentrations in serum
- High Sensitivity & Specificity: Reliable detection for prenatal screening, liver disease, and oncology diagnostics
- Reproducible Performance: Consistent results across laboratories and multiple assay runs
- Ready-to-Use Kit: Simplifies laboratory workflow and reduces hands-on preparation time
- Versatile Applications: Supports prenatal evaluation, liver cancer detection, tumour monitoring, and clinical research
This Biorex Diagnostics CLIA Kit is a trusted, accurate, and efficient solution for quantitative AFP testing. By enabling reliable assessment , the assay supports early disease detection, treatment monitoring, and research into fetal development, liver disorders, and oncology, ultimately improving clinical decision-making and patient care.
Contact Us for more information.